Results 31 to 40 of about 143,629 (328)

Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods [PDF]

, 2017
Opioid use disorder is a highly disabling psychiatric disorder, and is associated with both significant functional disruption and risk for negative health outcomes such as infectious disease and fatal overdose. Even among those who receive evidence-based
Barlow, David H., Fitzmaurice, Garrett M., Greenfield, Shelly F., McHugh, R. Kathryn, Votaw, Victoria R., Weiss, Roger D.   +5 more
core   +1 more source

Update on the clinical use of buprenorphine: in opioid-related disorders.

Canadian family physician Medecin de famille canadien, 2012
To review the current evidence on buprenorphine-naloxone for the treatment of opioid-related disorders, with a focus on primary care settings.MEDLINE and the Cochrane Database of Systematic Reviews were searched. Evidence is mainly level I.Buprenorphine is a partial μ-opioid agonist and κ-opioid antagonist with a long half-life and less abuse potential
Simon Ducharme, Ronald Fraser, Kathryn Gill   +2 more
openalex   +3 more sources

P068 STD screening and diagnosis among 15–24 year old diagnosed with prescription opioid related disorder [PDF]

Poster Presentations, 2019
Background Many injection drug users have elevated STD/HIV risks, such as sexual-trade for drugs, risky condom-less sex, or multiple sex partners. STD diagnosis and screening among opioid users has not been examined. Methods Using 2016 MarketScan commercial claims data, men and women aged 15–24 with opioid prescriptions were identified.
Chirag Patel, Kendra Cuffe, Guoyu Tao
openaire   +1 more source

Overlapping mechanisms of stress-induced relapse to opioid use disorder and chronic pain: Clinical implications

Frontiers in Psychiatry, 2016
Over the past two decades, a steeply growing number of persons with chronic non-cancer pain have been using opioid analgesics chronically to treat it, accompanied by a markedly increased prevalence of individuals with opioid-related misuse, opioid use ...
Udi E Ghitza
doaj   +1 more source

A primary care, multi-disciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity [PDF]

, 2005
BACKGROUND: Chronic non-cancer pain is a common problem that is often accompanied by psychiatric comorbidity and disability. The effectiveness of a multi-disciplinary pain management program was tested in a 3 month before and after trial.
A Rosenblum, AK Burton, AM Elliott, B McCarberg, B Meier, C Maier, CA Hammett-Stabler, CA Soderstrom, CD DeAngelis, CS Cleeland, CS Cleland, CS Cleland, D Bloodsworth, D Fujimoto, DA Fishbain, DA Regier, Darren A DeWalt, DC Turk, DC Turk, DE Joranson, DE Joranson, DE Moulin, DE Weissman, DG Rischitelli, DJ Kavanagh, H Flor, H Ghodse, H McQuay, J Gardner-Nix, J Porter, J Stephen Perhac, JD Bartleson, JD Clark, JE Veney, JK Iglehart, JM Harris Jr, JM Romano, JT Chibnall, JT Farrar, Katherine M Felix, KB Wells, L Allan, L Peters, L Radloff, L Webb, LH Pengel, LK Mannix, M van Tulder, Mary E Bryant, MC Reid, MC Rowbotham, ME Geisser, MF Ballesteros, MI Donovan, Michael P Pignone, MJ Bair, MJ Bair, NG Hoffmann, NJ Adams, OxyContin®, P Belluck, PA Hill, Paul R Chelminski, PE Greenberg, R Colvin, R Friedman, R Melzack, R Rothman, RA Deyo, RB Lipton, RB Lipton, RC Tait, RH Fletcher, RK Portenoy, RK Portenoy, RK Portenoy, RN Jamison, RN Jamison, Robert M Malone, RS Epstein, SA Dunbar, SD Passik, SG Gelfand, SH Roth, SM Fishman, SR Savage, SR Ytterberg, Steven D Prakken, T Bodenheimer, T Bodenheimer, T Bodenheimer, Thomas M Miller, Timothy J Ives, W Arkinstall, WF Stewart, Y Olsen   +95 more
core   +4 more sources

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: a systematic review and meta-analysis [PDF]

, 2014
<b>Background</b><p></p> It is assumed within the accumulated literature that children born of pregnant opioid dependent mothers have impaired neurobehavioral function as a consequence of chronic intrauterine opioid use.<p>&
A Baldacchino, A Liberati, A Ornoy, A Sameroff, A Verdejo-Garcia, AJ Dunlop, Alex Baldacchino, American Psychiatric Association, B Hanson, BJ Cleary, Britannica, C Konijnenberg, C Konijnenberg, Colin McCowan, DE Hutchings, Dennis J Petrie, Department of Health (England) and the devolved administrations, DF Stroup, E Rotheram-Fuller, E Strauss, EK Emory, FM Wolf, GJ Demakis, H Cooper, HC Steinhausen, HE Jones, HE Jones, I Fihrer, I van Beusekom, IM Bernstein, J Cohen, J Cohen, J Keegan, J Kimber, J Prosser, JE Hunter, JN Whitham, JP Higgins, K Spiteri Cornish, Kathleen Arbuckle, KB Walhovd, KD Ersche, KK Zakzanis, L Manchikanti, L McGlone, LV Hedges, LV Hedges, LW Anderson, M Borenstein, M Borenstein, M Connock, M Farrell, M Grattan, M Pirastu, MD Lezak, MM de Cubas, National Collaborating Centre for Methods and Tools, NICE, NICHD, PS Bauman, R Bunikowski, R Cornish, R Hamilton, R King, RE Johnson, RG Orwin, RJ Sternberg, RW Hunt, S Darke, S Minozzi, S Salo, S Simeons, S Soepatmi, S Tong, Scottish Government, SL Grace, SL Hans, SL Hans, SM Petterson, SM Quinhana, SR Kandall, TB Huedo-Medina, TJ Ornstein, TS Rosen, V Moe, WH Organization, WK Lombardo   +86 more
core   +12 more sources

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees

JAMA Health Forum, 2023
ImportanceThe opioid crisis disproportionately affects Medicaid enrollees, yet little systematic evidence exists regarding how prevalence of and health care utilization for opioid use disorder (OUD) vary across geographical areas.ObjectivesTo characterize state- and county-level variation in claims-based prevalence of OUD and rates of medication ...
Lindner, Stephan R., Hart, Kyle, Manibusan, Brynna, McCarty, Dennis, McConnell, K. John   +4 more
openaire   +2 more sources

Comorbidity of opioid-related and anxiety-related symptoms and disorders

Current Opinion in Psychology, 2019
Opioid use disorder and anxiety disorders co-occur at strikingly high rates, and this comorbidity is marked by a more severe clinical presentation and poorer prognosis for treatment. Given the substantial morbidity and mortality associated with these two disorders, it is imperative to understand factors related to the high rates of co-occurrence in ...
Kirsten J Langdon, Kathrine Dove, Susan Ramsey   +2 more
openaire   +3 more sources

Clinical effectiveness and treatment satisfaction between two triple‐therapy regimens in treating neuropathic pain: A real‐world data

Ibrain, EarlyView., 2023
This study compared the clinical effectiveness and treatment satisfaction of Pregabalin and Gabapentin triple therapy for neuropathic pain in a real‐world setting. The primary outcome measured the reduction in mean Self‐Administered Leeds Assessment of Neuropathic Symptoms and Signs pain score value from baseline to 12 weeks posttreatment.
Nithya Raju, Samyuktha Villavan, Saranya Ravi, Roja Murugesan, Panneerselvam Theivendren, Vennila Jaganathan, Redlin Jani Rajan, Krupanidhi Karunanithi   +7 more
wiley   +1 more source